Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.5500 (0.82%) ($29.5500 - $29.5500) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 34 | Latest Price | $29.5500(0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1% a day on average for past five trading days. | Weekly Trend | IOVA declines -7.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(41%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.92% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $17(-42.47%) | Inflection Point | Yes | Resistance Level | $32.08 | 5 Day Moving Average | $29.56(-0.03%) | 10 Day Moving Average | $30.64(-3.56%) | 20 Day Moving Average | $32.08(-7.89%) | To recent high | -43.8% | To recent low | 3.1% | Market Cap | $4.327b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |